BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND GNAQ, P50148, 2776, ENSG00000156052, G-ALPHA-q, RP11-494N1_1, GAQ
97360 results:

  • 1. From decision to reflection: understanding the experiences and unmet care needs of patients treated with immunotherapy for melanoma in the adjuvant or metastatic setting.
    Kamminga NCW; van der Veldt AAM; Wakkee M; van den Berge FR; van der Beek LAA; Joosen MCW; Joosse A; de Joode K; Nijsten TEC; Lugtenberg M
    BMC Cancer; 2024 May; 24(1):662. PubMed ID: 38816701
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Extracting Electronic Health Record Neuroblastoma Treatment Data With High Fidelity Using the REDCap Clinical Data Interoperability Services Module.
    Furner B; Cheng A; Desai AV; Benedetti DJ; Friedman DL; Wyatt KD; Watkins M; Volchenboum SL; Cohn SL
    JCO Clin Cancer Inform; 2024 May; 8():e2400009. PubMed ID: 38815188
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Ethnic disparities in complete and partial molar pregnancy incidence: a retrospective analysis of arab and jewish women in single medical center.
    Aiob A; Gumin D; Zilberfarb I; Naskovica K; Sgayer I; Mikhail SM; Sharon A; Lowenstein L
    BMC Public Health; 2024 May; 24(1):1440. PubMed ID: 38811887
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Beyond Clinical Trials: Understanding Neurotrophic Tropomyosin Receptor Kinase Inhibitor Challenges and Efficacy in Real-World Pediatric Oncology.
    Vince CSC; Brassesco MS; Mançano BM; Gregianin LJ; Carbone EK; do Amaral E Castro A; Dwan VSY; Menezes da Silva RZ; Mariano CS; da Mata JF; Silva MO; Caran EMM; Macedo CD; Alves da Costa G; Esteves TC; Silva LN; Ferman SE; Martins FD; Cristófani LM; Odone-Filho V; Silva MM; Reis RM; Pianovski MAD; Campregher PV; Kunii MS; de Sá Rodrigues KE; Carvalho Filho NP; Valera ET;
    JCO Precis Oncol; 2024 May; 8():e2300713. PubMed ID: 38810175
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Anticancer Activity of Aaptos suberitoides on Glioblastoma Multiforme cell Line.
    Huda F; Hermawan R; Putri T; Dwiwina RG; Berbudi A; Bashari MH
    Asian Pac J Cancer Prev; 2024 May; 25(5):1815-1821. PubMed ID: 38809654
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A novel lateral myelotomy approach for the treatment of lateral or ventrolateral spinal gliomas.
    Hang G; Gong Y; Xie H; Xie T
    Acta Neurochir (Wien); 2024 May; 166(1):237. PubMed ID: 38809310
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. (NDMA) METFORMIN AND (NTTP) SITAGLIPTIN INDUCED CUTANEOUS MELANOMAS: LINKS TO NITROSOGENESIS, NITROSO-PHOTOCARCINOGENESIS, ONCOPHARMACOGENESIS AND THE METABOLIC REPROGRAMMING.
    Tchernev G; Broshtilova V
    Georgian Med News; 2024 Mar; (348):132-143. PubMed ID: 38807407
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Safety and surgical outcomes of robotic adrenalectomy from a 15-year experience at a single institution.
    Kim K; Park D; Oh MY; Chai YJ; Kim HY
    Sci Rep; 2024 May; 14(1):12174. PubMed ID: 38806567
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Our experience in the treatment of congenital nasal median heterotopias in children and an overview of various treatment tactics].
    Molodtsova EV; Yunusov AS; Daikhes NA; Polyakov DP; Korobkin AS; Larina OM
    Vestn Otorinolaringol; 2024; 89(2):28-32. PubMed ID: 38805460
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Evaluation of pharmacokinetics, safety, and efficacy of [211At] meta-astatobenzylguanidine ([211At] MABG) in patients with pheochromocytoma or paraganglioma (PPGL): A study protocol.
    Kobayakawa M; Shiga T; Takahashi K; Sugawara S; Nomura K; Hanada K; Ishizuka N; Ito H
    PLoS One; 2024; 19(5):e0303623. PubMed ID: 38805424
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Optic nerve sheath diameter correlates with both success and failure of hydrocephalus treatment in pediatric patients with pineal region lesions.
    Zipfel J; Kerscher SR; Dhillon K; Ferraris KP; Singhal A
    Acta Neurochir (Wien); 2024 May; 166(1):236. PubMed ID: 38805061
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Immune cell populations in the tumour environment following calcium electropora-tion for cutaneous metastasis: a histopathological study.
    Vissing M; Sinius Pouplier S; Munch Larsen L; Krog Frandsen S; Lodin A; Lænkholm AV; Gehl J
    Acta Oncol; 2024 May; 63():398-410. PubMed ID: 38804839
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. SENP1-Mediated deSUMOylation Regulates the tumor Remodeling of Glioma Stem cells Under Hypoxic Stress.
    Wen P; Li H; Liu L; Liu X; Xu Z; Dong J
    Technol Cancer Res Treat; 2024; 23():15330338241257490. PubMed ID: 38803001
    [No Abstract]    [Full Text] [Related]  

  • 14. Two sisters diagnosed with familial paraganglioma syndrome type 1 (FPGL1) and multiple endocrine neoplasia type 2A (MEN2A).
    Stawarz K; Durzynska M; Galazka A; Paszkowska M; Bienkowska-Pluta K; Zwolinski J; Tysarowski A; Kwiatkowska E; Podgorska A
    World J Surg Oncol; 2024 May; 22(1):139. PubMed ID: 38802890
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Effect of Cannabis sativa L. extracts, phytocannabinoids and their acetylated derivates on the SHSY-5Y neuroblastoma cells' viability and caspases 3/7 activation.
    Tapia-Tapia E; Aránguiz P; Diaz R; Espinoza L; Weinstein-Oppenheimer CR; Cuellar M
    Biol Res; 2024 May; 57(1):33. PubMed ID: 38802872
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Tumour growth rate predicts overall survival in patients with recurrent WHO grade 4 glioma.
    Pang JHW; Saffari SE; Lee GR; Yu WY; Lim CCT; Lim KC; Lee CC; Koh WY; Chia WTD; Chua KLM; Tham CK; Low YYS; Ng WH; Low CYD; Lin X
    BMC Med Imaging; 2024 May; 24(1):125. PubMed ID: 38802734
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A novel APP splice variant-dependent marker system to precisely demarcate maturity in SH-SY5Y cell-derived neurons.
    Kulatunga DCM; Ranaraja U; Kim EY; Kim RE; Kim DE; Ji KB; Kim MK
    Sci Rep; 2024 May; 14(1):12113. PubMed ID: 38802572
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Case report: Is severe toxicity the price to pay for high sensitivity to checkpoint inhibitors immunotherapy in desmoplastic melanoma?
    Squicciarini T; Villani R; Apollonio B; Fucci L; Zambetti M; Rossini M; Pinto R; Tommasi S; De Roma I; Strippoli S; Guida M
    Front Immunol; 2024; 15():1369531. PubMed ID: 38799429
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A radiomics-based nomogram may be useful for predicting telomerase reverse transcriptase promoter mutation status in adult glioblastoma.
    Li Y; Chen L; Huang L; Li X; Huang Q; Tang L; Huang Z; Zhu L; Li T
    Brain Behav; 2024 May; 14(5):e3528. PubMed ID: 38798094
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. PKM2 promotes glioma progression by mediating CTNNB1 expression.
    Ma C; Feng Y; Zhong K; Wei J
    Neurol Res; 2024 Jul; 46(7):583-592. PubMed ID: 38797679
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4868.